Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A familial congenital mirror movement disorder where individuals with heterozygous variants in DCC have congenital mirror movements and/or agenesis of the corpus callosum (not with or without- some individuals do not demonstrate mirror movements and only have corpus callosum defects, even within the same family).
No HPO annotations are available for this condition.
Physiologic mild mirror movements may be seen in young children, but their persistence after age seven years is pathologic . The disorder of congenital mirror movements (CMM) is characterized by early-onset obvious mirror movements that persist throughout adulthood in individuals who typically have no other clinical disorders. In particular, the mirror movements are not usually associated with subsequent onset of additional neurologic manifestations. However, a subset of individuals with a heterozygous DCC pathogenic variant may have concomitant cognitive and/or neuropsychiatric issues, particularly if abnormalities of the corpus callosum are present (see and ). Mirror movements usually persist throughout life, without deterioration or improvement.
The diagnosis of the disorder of congenital mirror movements (CMM) is established by clinical findings and, in some instances, molecular genetic testing.
CMM should be suspected in individuals with the following clinical features, imaging findings, and family history.
Clinical features
Source: GeneReviews — "Congenital Mirror Movements"
No approved treatments are currently available for mirror movements 1 and/or agenesis of the corpus callosum. The disease remains an area of unmet medical need.
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with congenital mirror movements (CMM), the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 3. Recommended Evaluations Following Initial Diagnosis in Individuals with Congenital Mirror Movements
No clinical trials have been registered for mirror movements 1 and/or agenesis of the corpus callosum.
203 publications have been identified in PubMed for mirror movements 1 and/or agenesis of the corpus callosum. Kisho has analyzed 77 by research type. Research spans Review / Meta-Analysis (23%), Epidemiology / Natural History (22%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 18 | 23% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:36 PM UTC
Source: GeneReviews — "Congenital Mirror Movements"
The differential diagnosis of congenital mirror movements (CMM) from mirror movements of other causes is mainly theoretic, as the findings in CMM are distinctive, isolated, and easily recognized. Physiologic mirror movements. The intensity of the mirror movements and their persistence after age seven years clearly differentiate pathologic from physiologic mirror movements. Mild physiologic mirror movements are frequent in normally developing young children. They usually disappear completely before age seven years and tend to recur gradually in old age . Syndromes with early-onset (congenital) mirror movements. Early-onset mirror movements are not always isolated; they may be a component of complex syndromes and congenital hemiplegia (the most common form of cerebral palsy) . Although the clinical characteristics of mirror movements have been less comprehensively investigated in these conditions, they resemble those of CMM. In practice, differential diagnosis of CMM is rarely an issue, as the associated findings are generally more significant. When the diagnosis is in doubt, brain and cervical MRI may be considered in children or adolescents with mirror movements. Table 2. Syndromes with Early-Onset Mirror Movements
Disorder | Gene(s) | MOI | Mirror Movements | Other Features |
|---|---|---|---|---|
ANOS1 Kallmann syndrome (KS) (See Isolated GnRH Deficiency.) | ANOS1 (KAL1) | XL | MM in persons w/KS is almost always linked to ANOS11 (ANOS1-KS accounts for ~5%-10% of isolated GnRH deficiency).; Prevalence of MM in KAL1-KS is 75%.1 | Hyposmia hypogonadotropic hypogonadism |
Joubert syndrome | ≥34 genes | ARXL2 | CMM is observed in some affected persons.3 | Hypoplasia of cerebellar vermis w/characteristic neuroradiologic molar tooth sign variable accompanying neurologic symptoms Klippel-Feil syndrome (KFS) (OMIM PS118100)4 |
MYO18B | ADAR | MM is present in minority of persons w/KFS (MM is likely linked to cervicomedullary neuroschisis). | Congenital fusion of cervical vertebrae | — |
Typical phenotype incl low posterior hairline, short neck, amplitude of neck movements Moebius syndrome (OMIM 157900) | Unknown | AD | MM is only occasionally reported.5 | Minimum criteria are congenital, non-progressive facial weakness in assoc w/limited abduction of 1 or both eyes. |
Nevoid basal cell carcinoma syndrome(Gorlin syndrome) | PTCH1(PTCH2)6SUFU | AD | MM reported in 1 person7 | Multiple basal cell carcinomas, jaw keratocysts, skeletal malformations |
Seckel syndrome(OMIM PS210600) | ATRCPAP (CENPJ)CEP152CEP63DNA2NINNSMCE2RBBP8TRAIP | AR | 1 reported person w/MM8 | Primary microcephaly, intellectual disability, often prenatal-onset growth restriction |
Wildervanck syndrome (OMIM 314600) | Unknown | XL? | 1 reported person w/MM9 | Klippel-Feil syndrome w/congenital perceptive deafness Duane syndrome10; Affected persons are almost exclusively female. AD =... |
Source: GeneReviews — "Congenital Mirror Movements"
Biomarker and diagnostic research for mirror movements 1 and/or agenesis of the corpus callosum has been reported in the published literature.
System/Concern | Evaluation | Comment |
|---|---|---|
Neurologic | Evals to document difficulties w/ADL | Consider referral to rehab specialist. Consider head MRI imaging. |
counseling | By genetics professionals1 | To obtain a pedigree inform affected persons their families re nature, MOI, implications of CMM to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with Congenital Mirror Movements Manifestation/Concern | Treatment/Counseling | Considerations/Other |
Mirror movements | Adaptation of school environment | Incl allocation of extra time during exams limitation of amount of handwriting Avoid stigmatizing children adolescents. |
Neurocognitive deficits | Standard treatment | Consider referral to neurodevelopmental specialist. Complex bimanual movements or sustained/repetitive hand activity should be limited in order to reduce the occurrence of pain or discomfort in the upper limbs. |
Source: GeneReviews — "Congenital Mirror Movements"
Complex bimanual movements or sustained/repetitive hand activity should be limited in order to reduce the occurrence of pain or discomfort in the upper limbs.
Source: GeneReviews — "Congenital Mirror Movements"
Botulinum toxin injections have been successfully tried in one affected individual but are not usually proposed, as the risk of inducing a motor deficit generally exceeds the possible benefit. Noninvasive modulation of brain interhemispheric communication may be a possibility in the future . Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions.
Source: GeneReviews — "Congenital Mirror Movements"
View trials for mirror movements 1 and/or agenesis of the corpus callosum
Disease patterns and progression |
17 |
22% |
Patient case studies | 13 | 17% |
Laboratory research | 12 | 16% |
Clinical study results | 11 | 14% |
Testing and diagnosis research | 3 | 4% |
New treatment approaches | 2 | 3% |
Other research | 1 | 1% |
Serpieri V (2026). [PMID: 41720098](https://pubmed.ncbi.nlm.nih.gov/41720098/). *Am J Hum Genet*. [Gene Therapy / Novel Therapeutics]
Das JM (2026). [PMID: 31082030](https://pubmed.ncbi.nlm.nih.gov/31082030/). *Unknown Journal*. [Other]
Ayushma (2026). [PMID: 42182988](https://pubmed.ncbi.nlm.nih.gov/42182988/). *Front Mol Neurosci*. [Review / Meta-Analysis]
LeFebre NM (2026). [PMID: 41494597](https://pubmed.ncbi.nlm.nih.gov/41494597/). *Neuropsychologia*. [Epidemiology / Natural History]
Algahtani H (2026). [PMID: 40301278](https://pubmed.ncbi.nlm.nih.gov/40301278/). *Acta Neurol Belg*. [Review / Meta-Analysis]
Rashid R (2026). [PMID: 40545644](https://pubmed.ncbi.nlm.nih.gov/40545644/). *J Child Neurol*. [Epidemiology / Natural History]
Cao GH (2025). [PMID: 41239616](https://pubmed.ncbi.nlm.nih.gov/41239616/). *Medicine (Baltimore)*. [Case Report / Case Series]
Libzon S (2025). [PMID: 39259028](https://pubmed.ncbi.nlm.nih.gov/39259028/). *Dev Med Child Neurol*. [Diagnostic / Biomarker]
Vidyawan V (2025). [PMID: 39385328](https://pubmed.ncbi.nlm.nih.gov/39385328/). *Autophagy*. [Basic Science / Preclinical]
Piton A (2025). [PMID: 40555137](https://pubmed.ncbi.nlm.nih.gov/40555137/). *Curr Opin Genet Dev*. [Review / Meta-Analysis]